tiprankstipranks
Bellicum Pharmaceuticals Issues Super-Voting Share Privately
Market News

Bellicum Pharmaceuticals Issues Super-Voting Share Privately

Bellicum Pharmaceuticals (BLCM) has released an update to notify the public and investors about the unregistered sales of equity securities.

Don't Miss our Black Friday Offers:

On January 24, 2024, Bellicum Pharmaceuticals, Inc. issued one share of Series A Junior Preferred Stock, known as the Super-Voting Share, to current director Richard A. Fair for $0.01. This private transaction was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as it was not a public offering.

For further insights into BLCM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBellicum Pharmaceuticals Appoints New CEO During Dissolution
TipRanks Auto-Generated NewsdeskBellicum Pharmaceuticals Finalizes Sale and Approves Dissolution
Catie PowersBellicum Pharmaceuticals Asset Sale and Dissolution Vote Adjourned
Go Ad-Free with Our App